Assyro AI

Orange Book product · Generic (ANDA)

MIVACURIUM CHLORIDE

MIVACURIUM CHLORIDE

Generic (ANDA)ANDA 209708DISCN WOODWARD

At a glance

Oct 12, 2021

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 12, 2021

    4 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MIVACURIUM CHLORIDE

Strength

EQ 10MG BASE/5ML (EQ 2MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

ANDA 209708

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MIVACURIUM CHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.